BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30655993)

  • 1. Non-specific elevation of serum Mac-2 binding protein glycosylation isomer levels in patients with biliary disease.
    Takagi T; Suzuki R; Sugimoto M; Konno N; Sato Y; Irie H; Watanabe K; Nakamura J; Takasumi M; Hikichi T; Ohira H
    Mol Clin Oncol; 2019 Jan; 10(1):168-172. PubMed ID: 30655993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury.
    Seike T; Komura T; Shimizu Y; Omura H; Kumai T; Kagaya T; Ohta H; Kawashima A; Harada K; Kaneko S; Unoura M
    Intern Med; 2020 Jul; 59(13):1581-1588. PubMed ID: 32269188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
    Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
    World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Mac-2-binding protein glycosylation isomer level with nutritional status in chronic liver disease.
    Eso Y; Takai A; Taura K; Takahashi K; Ueda Y; Marusawa H; Seno H
    J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29473206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).
    Ueno T; Takase K; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2022 Dec; 38(12):1807-1813. PubMed ID: 36125546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
    J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
    Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
    Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia.
    Ueno T; Kodama T; Noguchi Y; Saka R; Takama Y; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2018 Oct; 34(10):1065-1071. PubMed ID: 30128700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
    Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
    Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
    Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
    Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Serum Mac-2 Binding Protein in Patients After Living Donor Liver Transplantation for Biliary Atresia.
    Ueno T; Takase K; Deguchi K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Kimura T; Okuyama H
    Transplant Proc; 2024 Mar; 56(2):343-347. PubMed ID: 38360465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.
    Morio K; Imamura M; Daijo K; Teraoka Y; Honda F; Nakamura Y; Kobayashi T; Nakahara T; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Kawakami Y; Aikata H; Nelson Hayes C; Tsugawa K; Yokozaki M; Chayama K
    J Gastroenterol; 2017 Dec; 52(12):1252-1257. PubMed ID: 28477171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy: A case controlled study.
    Hiyoshi M; Yano K; Nanashima A; Ikenoue M; Imamura N; Fujii Y; Hamada T; Nishida T
    Ann Med Surg (Lond); 2019 Dec; 48():17-22. PubMed ID: 31692665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
    Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
    Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
    Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
    Suzuki T; Matsuura K; Nagura Y; Ogawa S; Fujiwara K; Nojiri S; Watanabe T; Kataoka H; Tanaka Y
    Hepatol Res; 2022 Nov; 52(11):919-927. PubMed ID: 35938598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases.
    Jang SY; Tak WY; Park SY; Kweon YO; Lee YR; Kim G; Hur K; Han MH; Lee WK
    Ann Lab Med; 2021 May; 41(3):302-309. PubMed ID: 33303715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study.
    Park HJ; Seo KI; Lee SU; Han BH; Yun BC; Park ET; Lee J; Hwang H; Yoon M
    Medicine (Baltimore); 2022 Oct; 101(40):e30489. PubMed ID: 36221351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.